Un-BAFFling gray matter pathology in multiple sclerosis

Sci Immunol. 2024 Apr 5;9(94):eadp4667. doi: 10.1126/sciimmunol.adp4667. Epub 2024 Apr 5.

Authors

Dane Ford-Roshon¹, Andrew S Mendiola¹

Affiliation

¹ Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.

PMID: 38579016
DOI: 10.1126/sciimmunol.adp4667

Abstract

BAFF mediates the neuroprotective effects of B cell depletion therapy in multiple sclerosis.

MeSH terms

Gray Matter* / pathology
Humans
Multiple Sclerosis* / pathology

Grants and funding

R00 NS126707/NS/NINDS NIH HHS/United States